Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Large Decline in Short Interest

Ocean Biomedical, Inc. (NASDAQ:OCEAW) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 4,000 shares, a decrease of 42.0% from the February 28th total of 6,900 shares. Based on an average daily trading volume, of 58,100 shares, the days-to-cover ratio is presently 0.1 days.

Ocean Biomedical Trading Down 8.7 %

Shares of Ocean Biomedical stock opened at $0.02 on Monday. The business’s 50 day moving average price is $0.03 and its 200 day moving average price is $0.03. Ocean Biomedical has a one year low of $0.02 and a one year high of $0.36.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.